Biopharma Quarterly Dealmaking Statistics, Q3 2018
A look at financing, M&A and alliance activity July-September 2018
Biopharma financing reached $14.6 billion in the third quarter, a 15% increase over Q2, while merger and acquisitions, at $7.7 billion (the lowest quarter of the year so far), showed a sharp decline. Alliance value reached $20.3 billion, far exceeding the $13.8 billion from Q2.